rs266875
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000593997.5(KLK3):c.*32G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.558 in 1,496,438 control chromosomes in the GnomAD database, including 236,436 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.60 ( 27928 hom., cov: 31)
Exomes 𝑓: 0.55 ( 208508 hom. )
Consequence
KLK3
ENST00000593997.5 3_prime_UTR
ENST00000593997.5 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.561
Publications
9 publications found
Genes affected
KLK3 (HGNC:6364): (kallikrein related peptidase 3) Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. The gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. It encodes a single-chain glycoprotein, a protease which is synthesized in the epithelial cells of the prostate gland, and is present in seminal plasma. It is thought to function normally in the liquefaction of seminal coagulum, presumably by hydrolysis of the high molecular mass seminal vesicle protein. The serum level of this protein, called PSA in the clinical setting, is useful in the diagnosis and monitoring of prostatic carcinoma. Alternate splicing of this gene generates several transcript variants encoding different isoforms. [provided by RefSeq, Dec 2019]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.743 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| KLK3 | NM_001648.2 | c.630+86G>A | intron_variant | Intron 4 of 4 | ENST00000326003.7 | NP_001639.1 | ||
| KLK3 | NM_001030047.1 | c.630+86G>A | intron_variant | Intron 4 of 4 | NP_001025218.1 | |||
| KLK3 | NM_001030048.1 | c.501+86G>A | intron_variant | Intron 4 of 4 | NP_001025219.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| KLK3 | ENST00000326003.7 | c.630+86G>A | intron_variant | Intron 4 of 4 | 1 | NM_001648.2 | ENSP00000314151.1 |
Frequencies
GnomAD3 genomes AF: 0.596 AC: 90478AN: 151892Hom.: 27895 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
90478
AN:
151892
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.565 AC: 120919AN: 214090 AF XY: 0.574 show subpopulations
GnomAD2 exomes
AF:
AC:
120919
AN:
214090
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.553 AC: 743853AN: 1344428Hom.: 208508 Cov.: 19 AF XY: 0.558 AC XY: 372585AN XY: 667972 show subpopulations
GnomAD4 exome
AF:
AC:
743853
AN:
1344428
Hom.:
Cov.:
19
AF XY:
AC XY:
372585
AN XY:
667972
show subpopulations
African (AFR)
AF:
AC:
23741
AN:
31140
American (AMR)
AF:
AC:
19302
AN:
40886
Ashkenazi Jewish (ASJ)
AF:
AC:
12360
AN:
23160
East Asian (EAS)
AF:
AC:
19079
AN:
38792
South Asian (SAS)
AF:
AC:
56672
AN:
78974
European-Finnish (FIN)
AF:
AC:
24463
AN:
49772
Middle Eastern (MID)
AF:
AC:
3315
AN:
5422
European-Non Finnish (NFE)
AF:
AC:
553373
AN:
1020282
Other (OTH)
AF:
AC:
31548
AN:
56000
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
16735
33470
50206
66941
83676
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
15704
31408
47112
62816
78520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.596 AC: 90563AN: 152010Hom.: 27928 Cov.: 31 AF XY: 0.596 AC XY: 44281AN XY: 74286 show subpopulations
GnomAD4 genome
AF:
AC:
90563
AN:
152010
Hom.:
Cov.:
31
AF XY:
AC XY:
44281
AN XY:
74286
show subpopulations
African (AFR)
AF:
AC:
31124
AN:
41480
American (AMR)
AF:
AC:
7836
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
1844
AN:
3470
East Asian (EAS)
AF:
AC:
2569
AN:
5140
South Asian (SAS)
AF:
AC:
3521
AN:
4826
European-Finnish (FIN)
AF:
AC:
5126
AN:
10548
Middle Eastern (MID)
AF:
AC:
187
AN:
294
European-Non Finnish (NFE)
AF:
AC:
36585
AN:
67946
Other (OTH)
AF:
AC:
1252
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1827
3655
5482
7310
9137
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
750
1500
2250
3000
3750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2162
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.